HighTower Advisors
VAXX

HighTower Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

HighTower Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,304
Closed -$13K – 3984
2024
Q1 		$13K Sell
17,304
-4,772
-22% -$3.46K ﹤0.01% 3389
2023
Q4 		$19K Buy
+22,076
New +$21.3K ﹤0.01% 3401
2022
Q4 		– Sell
-10,483
Closed -$20K – 3554
2022
Q3 		$20K Hold
10,483
– – ﹤0.01% 2974
2022
Q2 		$16K Buy
+10,483
New +$39.6K ﹤0.01% 3026

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

HighTower Advisors's VAXX Position: Q2 2024 in Review

HighTower Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 17,304 shares — an estimated $13K sold.

HighTower Advisors first reported a position in VAXX in Q2 2022 and held it in 4 quarters. The position peaked at $20K in Q3 2022. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • HighTower Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 17,304 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $13K.
  • HighTower Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
  • HighTower Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $20K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.